The hearing comes after the Institute of Medicine report last year that recommended improving diagnosis, treatment and research into chronic pain.
Panelists were:
• Lawrence A. Tabak, DDS, PhD, principal deputy director, National Institutes of Health, Washington, D.C.
• Philip A. Pizzo, MD, dean of the School of Medicine, Stanford (Calif.) University School of Medicine
• John E. Sarno, MD, professor of clinical rehabilitation medicine, New York University School of Medicine, New York City
• William Maixner, DDS, PhD, director, Center for Neurosensory Disorders, University of North Carolina at Chapel Hill
• Christin Veasley, executive director, National Vulvodynia Association, North Kingstown, R.I.
Sign up for our FREE Pain E-Weekly for more coverage like this sent to your inbox!
Related Articles on Pain Management:
Pain Physicians: How Does Your Practice Ensure Patient Satisfaction?
The “Unsafe Triangle”: Why Dr. Scott Glaser Believes Traditional Approaches to Transforaminal Epidural Steroid Injections Increase the Risk of Paraplegia
NIH Announces Members of Interagency Pain Research Coordinating Committee
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
